Open research questions in Epilepsy research and treatment
777 gap statements mined from Epilepsy research and treatment papers in our 7.9M-paper local library, which holds 4,531 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.
Choosing where to publish on Epilepsy research and treatment? See the ranked Medicine journals.
What the literature leaves open
The study had limited data on time-related outcomes and adverse events. The study had to deal with inadequate handling of censoring in the included studies.
Levetiracetam versus valproate for new-onset or previously treated but inadequately controlled epilepsy in children: a systematic review and meta-analysis of randomized controlled trials · 2026 · DOIOne challenge is the inconsistent findings on the association between ABCC2 polymorphisms and antiseizure medication resistance. Another challenge is the lack of statistical power in many of the included studies. The study also faces the challenge of heterogeneity across studies, which is addressed using random-effects meta-analysis.
ABCC2 rs2273697, rs717620, rs3740066 polymorphisms and antiseizure medication resistance: a systematic review and meta-analysis · 2026 · DOIThe study faced challenges in collecting data from adolescents with epilepsy, including the need for written informed consent from parents or legal guardians. The study had to exclude individuals with intellectual disability or communicative barriers that prevented the adolescent from accurately understanding and independently completing the quality of life questionnaire.
Factors associated with quality of life among adolescents with epilepsy: a cross-sectional study using the QOLIE-AD-48 questionnaire · 2026 · DOIThe study aims to explore the demographic and clinical factors related to health-related quality of life in adolescents with epilepsy. The paper does not explicitly state other research gaps.
Factors associated with quality of life among adolescents with epilepsy: a cross-sectional study using the QOLIE-AD-48 questionnaire · 2026 · DOIThere is a scarcity of data on epilepsy genetics in Africa. More than two-third of African nations have not had a single publication in epilepsy genetics. The lack of widespread availability of molecular diagnosis capabilities is a significant challenge.
The lack of adequate instruments to evaluate the impact of Dravet syndrome on behavior is a significant challenge. The need to consider the level of intellectual disability frequently observed in individuals with Dravet syndrome adds to the complexity of assessing aggressive behavior.
Altered network connectivity has emerged as a candidate biomarker of the epileptogenic zone, but how connectivity is altered in the epileptogenic zone remains uncertain, with prior studies reporting inconsistent results.
Intrinsic and extrinsic connectivity of the seizure onset zone at rest and during stimulation · 2026 · DOIHowever, the precise mechanisms underlying depression in epilepsy remain unclear.
Depression in Epilepsy: Drug and Non-Drug Interventions Based on Multimodal Pathogenesis · 2026 · DOIThe complementary targeting of this pathway by BFT and PHT offers a promising strategy to enhance antiseizure efficacy while mitigating PHT-induced neurotoxicity, warranting further investigation in drug-resistant epilepsy models.
The MID1IP1/S100A10-mGluR5 Axis in Seizures: Immune-Metabolic Crosstalk and Enhanced Therapeutic Efficacy of Benfotiamine/Phenytoin Combination · 2026 · DOIThere was limited evidence of layer-specific laminar thinning, being confined to layer VI in the right TLE/HS group only.
Histological morphometric correlates of MRI-defined cortical thinning in temporal lobe epilepsy · 2026 · DOIFurthermore, neuronal excitation-inhibition (E/I) dynamics-a key pathophysiological mechanism-has not yet been systematically characterized for clinical translation.
Localizing the Epileptogenic Zone Using SEEG-Based Excitation–Inhibition Dynamics and Spectral Features in Drug-Resistant Epilepsy: A Multicenter Retrospective Study · 2026 · DOIThe association between post stroke epilepsy (PSE) and revascularization therapy in stroke patients remains controversial.
Post-stroke epilepsy in revascularized versus not revascularized stroke patients: A prospective cohort study · 2026 · DOIHowever, the underlying disease mechanisms and therapeutic strategies remain poorly understood.
Rapamycin rescues neuronal hyperexcitability and seizures driven by megalencephaly-causing AKT3 activation · 2026 · DOIAlthough the AKT inhibitor capivasertib may provide targeted treatment, its long-term use from infancy is limited by adverse effects.
Rapamycin rescues neuronal hyperexcitability and seizures driven by megalencephaly-causing AKT3 activation · 2026 · DOIAlthough extensively studied, the events that result in SUDEP remain poorly understood, with no reliable biomarkers to predict SUDEP risk in an individual.
Pathophysiology of sudden unexpected death in epilepsy: a devasting convergence of dysfunction in brain, respiratory systems, and heart · 2026 · DOIWhile microglia are a predominant source of brain‐derived neurotrophic factor (BDNF) in the acute phase after brain injury, the role of microglial BDNF and its signaling in KCC2 dysregulation and early post‐stroke seizure susceptibility remain poorly defined.
KCC2 Dysfunction Mediated by Microglial BDNF / TrkB Signaling Exacerbates Early Post‐Stroke Seizure Susceptibility · 2026 · DOIWhile various animal models of mesial temporal lobe epilepsy (MTLE) exist, a validated model based solely on hippocampal GABAergic interneuron loss is lacking.
Ablation of Unilateral Hippocampal GABAergic Neurons: A Novel Mouse Model of Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis · 2026 · DOITemporal lobe epilepsy (TLE) is characterized by synaptic dysfunction for which targeted therapies are lacking.
HSDL2 Suppresses Epileptic Seizures Through Phosphorylation‐Dependent Modulation of the PSD95 ‐ NMDAR Signaling Axis · 2026 · DOIMCC-135 has shown potential as an antiseizure medication due to its ability to downregulate NCX and reduce intracellular calcium overload; however, its role and mechanism in epilepsy remain unclear.
MCC ‐135 Exerts Antiepileptic and Neuroprotective Effects by Downregulating NCX1 Expression to Decrease Intracellular Calcium Overload in the Hippocampus · 2026 · DOIFuture research should focus on improving robustness and reproducibility to facilitate clinical translation.
However, whether these associations reflect causality and whether SUA provides incremental predictive value beyond established clinical factors remains unknown.
Serum Uric Acid as a Sex‐Dependent Risk Marker of Post‐Stroke Epilepsy After Acute Ischemic Stroke: Complementary Mendelian Randomization and Cohort Analyses · 2026 · DOIThe prognostic significance of other supportive techniques such as Computed Tomography (CT) brain data and electroencephalograph (EEG) in PSE prediction is poorly understood.
Post-stroke epilepsy in revascularized versus not revascularized stroke patients: A prospective cohort study · 2026 · DOIInvestigate the effects of PTZ on cognitive functions, - Examine the long-term effects of PTZ and mechanical stress, - Explore the use of other experimental models to validate…
Sodium valproate and gabapentin reduce the seizure-like behavior induced by pentylenetetrazol and mechanical stress in Drosophila melanogaster: sex influence on behavioral responses · 2026 · DOILow-certainty evidence for seizure freedom, - Inadequate handling of censoring for time-related outcomes, - Substantial heterogeneity among the included studies for AST levels, - Very low certainty of evidence for change in AST, - Limited by the small number…
Levetiracetam versus valproate for new-onset or previously treated but inadequately controlled epilepsy in children: a systematic review and meta-analysis of randomized controlled trials · 2026 · DOIDeveloping a specific tool to assess aggressive behavior in Dravet syndrome. Creating supportive therapies not only for patients but also for caregivers and family members.
Most-cited papers in Epilepsy research and treatment
- Early Identification of Refractory Epilepsy · New England Journal of Medicine · 2000 · 4,372 citations
- A Randomized, Controlled Trial of Surgery for Temporal-Lobe Epilepsy · New England Journal of Medicine · 2001 · 2,951 citations
- Epilepsy in adults · The Lancet · 2019 · 2,057 citations
- Early Surgical Therapy for Drug-Resistant Temporal Lobe Epilepsy · JAMA · 2012 · 1,129 citations
- American Clinical Neurophysiology Society's Standardized Critical Care EEG Terminology: 2021 Version · Journal of Clinical Neurophysiology · 2021 · 972 citations
- Resective Epilepsy Surgery for Drug-Resistant Focal Epilepsy · JAMA · 2015 · 625 citations
- National and State Estimates of the Numbers of Adults and Children with Active Epilepsy — United States, 2015 · MMWR Morbidity and Mortality Weekly Report · 2017 · 571 citations
- Being epileptic: coming to terms with stigma · Sociology of Health & Illness · 1986 · 564 citations
- A National Profile of Childhood Epilepsy and Seizure Disorder · PEDIATRICS · 2012 · 488 citations
- Prognosis in Children With Febrile Seizures · PEDIATRICS · 1978 · 487 citations
Most recent work
- Zorevunersen in Children and Adolescents with Dravet Syndrome · New England Journal of Medicine · 2026
- Epileptic activity in Alzheimer's disease: emerging insights and therapeutic implications · The Lancet Neurology · 2026
- Ictal–interictal continuum and status epilepticus: Two sides of the same coin? A prospective magnetic resonance imaging study · Epilepsia · 2026
- Innate immune signalling, neuroinflammation and network plasticity in temporal lobe epilepsy · Frontiers in Pharmacology · 2026
- Impact of Etiology on Mortality and Recovery in Patients With Status Epilepticus · Neurology · 2026
- Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy · JAMA Neurology · 2026
- Development and International Validation of a Novel Imaging-Based Risk Score (IsCHEMiA) for the Prediction of Poststroke Epilepsy · Neurology · 2026
- Safety and efficacy of eslicarbazepine acetate for seizure prevention in patients with stroke at high risk of developing post-stroke epilepsy: a proof-of-concept, phase 2a, randomised, double-blind, placebo-controlled antiepileptogenesis trial · The Lancet Neurology · 2026
- Ameliorating Seizures in Dravet Syndrome: A Review of Newly Approved and Investigational Drugs, RNA and Gene-Based Therapies · CNS Drugs · 2026
- Brain Structural Changes and Cognitive-Clinical Profiles in Late-Onset Unexplained Epilepsy · Neurology · 2026
Find a gap in your own Epilepsy research and treatment sub-topic
This page shows what the Epilepsy research and treatment literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 7.9M-paper local library and writes the gaps from its rows.
Open the Research Gap Finder →